Nuzenio

Ctim

Ctim news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 13 latest news signals 8 publisher sources 100/100 entity strength

Latest news

Context drops bispecific T-cell engager on cost-cutting initiative - Clinical Trials ArenaClinical Trials Arena · Fri, 07 Aug 2026 10:14:16 GMTAnalyst Reaffirms Buy on Context Therapeutics, Citing Undervalued Pipeline and CTIM-76 as Key Long-Term Driver - TipRanksTipRanks · Thu, 06 Aug 2026 17:52:17 GMTAnalyst Reiterates Buy on CTI with Unchanged $5 Price Target, Citing CTIM-76 Differentiation and Strategic Focus on CT-202 - TipRanksTipRanks · Thu, 06 Aug 2026 10:36:07 GMTContext scraps bispecific T-cell engager program to extend cash runway deeper into 2027 - Fierce BiotechFierce Biotech · Thu, 06 Aug 2026 09:55:15 GMTKey facts: NASDAQ:CNTX to dose CT-202 in Q3'26; shares -30%; $5 target - TradingViewTradingView · Thu, 06 Aug 2026 07:14:59 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - BenzingaBenzinga · Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Ends CT-95, Focuses on Two Cancer Programs - Stock TitanStock Titan · Thu, 06 Aug 2026 01:23:30 GMTContext Therapeutics Reports Second Quarter 2026 Operating and Pipeline Progress - The Manila TimesThe Manila Times · Wed, 05 Aug 2026 20:30:41 GMT

Timeline

Fri, 07 Aug 2026 10:14:16 GMTContext drops bispecific T-cell engager on cost-cutting initiative - Clinical Trials Arena
Thu, 06 Aug 2026 17:52:17 GMTAnalyst Reaffirms Buy on Context Therapeutics, Citing Undervalued Pipeline and CTIM-76 as Key Long-Term Driver - TipRanks
Thu, 06 Aug 2026 10:36:07 GMTAnalyst Reiterates Buy on CTI with Unchanged $5 Price Target, Citing CTIM-76 Differentiation and Strategic Focus on CT-202 - TipRanks
Thu, 06 Aug 2026 09:55:15 GMTContext scraps bispecific T-cell engager program to extend cash runway deeper into 2027 - Fierce Biotech
Thu, 06 Aug 2026 07:14:59 GMTKey facts: NASDAQ:CNTX to dose CT-202 in Q3'26; shares -30%; $5 target - TradingView
Thu, 06 Aug 2026 05:32:01 GMTContext Therapeutics Stock (CNTX) is Falling After Hours: Here's What's Driving the Move - Benzinga

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Ctim.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

8 distinct publisher/source names are currently connected to this entity page.